Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease

References

1. ↵
   1. Guilherme L,
   2. Köhler KF,
   3. Postol E,
   4. Kalil J

   (2011) Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol 4:13–21.

   OpenUrlCrossRefPubMed
2. ↵
   1. Tibazarwa KB,
   2. Volmink JA,
   3. Mayosi BM

   (2008) Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94:1534–1540.

   OpenUrlAbstract/FREE Full Text
3. ↵
   1. Al-Sekait MA,
   2. Al-Sweliem AA,
   3. Tahir M

   (1990) Rheumatic heart disease in schoolchildren in western district, Saudi Arabia. J R Soc Health 110:15–6, 19.

   OpenUrlPubMed
4. ↵
   1. Qurashi MA

   (2009) The pattern of acute rheumatic fever in children: Experience at the children's hospital, Riyadh, Saudi Arabia. J Saudi Heart Assoc 21:215–220.

   OpenUrl
5. ↵
   1. Guilherme L,
   2. Kalil J

   (2013) Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine. Front Immunol 4:352.

   OpenUrl
6. ↵
   1. Abbag F,
   2. Benjamin B,
   3. Kardash MM,
   4. al Barki A

   (1998) Acute rheumatic fever in southern Saudi Arabia. East Afr Med J 75:279–281.

   OpenUrlPubMed
7. ↵
   1. Jiang F,
   2. Yang J,
   3. Zhang Y,
   4. Dong M,
   5. Wang S,
   6. Zhang Q,
   7. et al.

   (2014) Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol 11:413–426.

   OpenUrlCrossRefPubMed
8. ↵
   1. Soubrier F

   (2013) From an ACE polymorphism to genome-wide searches for eQTL. J Clin Invest 123:111–112.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Chou HT,
   2. Tsai CH,
   3. Tsai FJ

   (2004) Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 45:949–957.

   OpenUrlCrossRefPubMed
10. ↵
    1. Davutoglu V,
    2. Nacak M

    (2005) Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. J Heart Valve Dis 14:277–281.

    OpenUrlPubMed
11. ↵
    1. Gupta U,
    2. Mishra A,
    3. Rathore SS,
    4. Agarwal SK,
    5. Pande S,
    6. Garg N,
    7. et al.

    (2013) Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease in Indian population and meta-analysis. Mol Cell Biochem 382:75–82.

    OpenUrlPubMed
12. ↵
    1. Morsy MM,
    2. Abdelaziz NA,
    3. Boghdady AM,
    4. Ahmed H,
    5. Abu Elfadl EM,
    6. Ismail MA

    (2011) Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children. Rheumatol Int 31:17–21.

    OpenUrlPubMed
13. ↵
    1. Burke RJ,
    2. Chang C

    (2014) Diagnostic criteria of acute rheumatic fever. Autoimmun Rev 13:503–507.

    OpenUrl
14. ↵
    1. Millum J,
    2. Wendler D,
    3. Emanuel EJ

    (2013) The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA 310:2143–2144.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Saracevic A,
    2. Simundic AM,
    3. Celap I,
    4. Luzanic V

    (2013) Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem. Mol Biol Rep 40:4459–4463.

    OpenUrl
16. ↵
    1. Saab YB,
    2. Gard PR,
    3. Overall AD

    (2007) The geographic distribution of the ACE II genotype: a novel finding. Genet Res 89:259–267.

    OpenUrlPubMed
17. ↵
    1. Rudnicki M,
    2. Mayer G

    (2009) Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics 10:463–476.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Chung CM,
    2. Wang RY,
    3. Fann CS,
    4. Chen JW,
    5. Jong YS,
    6. Jou YS,
    7. et al.

    (2013) Fine-mapping angiotensin-converting enzyme gene: separate QTLs identified for hypertension and for ACE activity. PLoS One 8:e56119.

    OpenUrl
19. ↵
    1. Ngo DT,
    2. Sverdlov AL,
    3. Horowitz JD

    (2012) Prevention of aortic valve stenosis: a realistic therapeutic target? Pharmacol Ther 135:78–93.

    OpenUrlCrossRefPubMed
20. ↵
    1. Simolin MA,
    2. Pedersen TX,
    3. Bro S,
    4. Mäyränpää MI,
    5. Helske S,
    6. Nielsen LB,
    7. et al.

    (2009) ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model. BMC Cardiovasc Disord 9:10.

    OpenUrlCrossRefPubMed
21. ↵
    1. Heidari F,
    2. Vasudevan R,
    3. Mohd Ali SZ,
    4. Ismail P,
    5. Etemad A,
    6. Pishva SR,
    7. et al.

    (2014) Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene among Malay male hypertensive subjects in response to ACE inhibitors. J Renin Angiotensin Aldosterone Syst, pii: 1470320314538878.